Literature DB >> 83326

Immune response in urinary tract infection determined by radioimmunoassay and immunofluorescence: serum antibody levels against infecting bacterium and Enterobacteriaceae common antigen.

B A Sanford, V L Thomas, M Forland, S Carson, A Shelokov.   

Abstract

A solid-phase radioimmunoassay (RIA) procedure was compared with the indirect fluorescent antibody (IFA) test in a serological study of 76 female adults with urinary tract infections. Relative serum antibody activity was determined against patients' homologous infecting enterobacteria by RIA and IFA and against heterologous enterobacterial common antigen (Escherichia coli O14) by RIA. There was marked correlation between results of the IFA and RIA methods using the homologous system; 22 of 51 patients (43%) with pyelonephritis had significantly elevated serum antibody activity by both IFA (titers greater than or equal to 512) and RIA (binding ratio greater than or equal to 2.0) when compared with normal serum controls; three had significant antibody activity detectable by RIA only. Eighteen (72%) of 25 patients with pyelonephritis had RIA binding ratios of greater than or equal to 2.0 against their homologous bacterial isolates and the enterobacterial common antigen; an additional 6 patients had binding ratios of greater than or equal to 2.0 against the antigen only. All 25 patients with cystitis had low serum antibody levels by IFA and RIA when tested against their own isolate as well as enterobacterial common antigen. The RIA procedure was objective, quantitative, and less tedious to perform than IFA.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 83326      PMCID: PMC275299          DOI: 10.1128/jcm.8.5.575-579.1978

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Antibody-coated bacteria in urinary tract infection.

Authors:  V L Thomas; M Forland; A Shelokov
Journal:  Kidney Int Suppl       Date:  1975-08       Impact factor: 10.545

2.  Antibody-coated bacteria in the urine of obstetrical patients with acute pyelonephritis.

Authors:  V L Thomas; R E Harris; L C Gilstrap; A Shelokov
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

3.  STUDY OF HETEROGENETIC (KUNIN) ANTIBODIES IN SERUM OF HEALTHY SUBJECTS AND CHILDREN WITH ENTERIC AND URINARY TRACT INFECTIONS.

Authors:  H Y WHANG; E NETER
Journal:  J Pediatr       Date:  1963-09       Impact factor: 4.406

4.  Magnetic transfer devices for use in solid-phase radioimmunoassays and enzyme-linked immunosorbent assays.

Authors:  K O Smith; W D Gehle
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

5.  Antibody-coated bacteria in the urine and the site of urinary-tract infection.

Authors:  V Thomas; A Shelokov; M Forland
Journal:  N Engl J Med       Date:  1974-03-14       Impact factor: 91.245

6.  Solid-phase radioimmunoassay of total and influenza-specific immunoglobulin G.

Authors:  H Daugharty; D T Warfield; M L Davis
Journal:  Appl Microbiol       Date:  1972-02

7.  Antibody response to the common enterobacterial antigen of children with shigellosis, salmonellosis or urinary tract infection.

Authors:  F Diaz; E Neter
Journal:  Am J Med Sci       Date:  1968-07       Impact factor: 2.378

Review 8.  Enterobacterial common antigen.

Authors:  P H Mäkelä; H Mayer
Journal:  Bacteriol Rev       Date:  1976-09

9.  Quantitation of Escherichia coli O antibodies by direct and indirect agglutination in comparison with a radioimmunoassay.

Authors:  S Ahlstedt; U Jodal; L A Hanson; J Holmgren
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

10.  Radioimmunoassay procedure for quantitating bacterial antibody in human sera.

Authors:  B A Sanford; K O Smith
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

  10 in total
  8 in total

1.  Detection of IgG antibodies against Bordetella pertussis with 125I-protein A.

Authors:  C H von König; H Finger
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

2.  Specific immune responses to skin test antigens following repeated multiple antigen skin tests in normal individuals.

Authors:  B Lesourd; W D Winters
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

3.  Rapid bead counting and dispensing device for radioimmunoassays and enzyme-linked immunosorbent assays.

Authors:  G W Hui
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

4.  Mast cell interleukin-10 drives localized tolerance in chronic bladder infection.

Authors:  Cheryl Y Chan; Ashley L St John; Soman N Abraham
Journal:  Immunity       Date:  2013-02-15       Impact factor: 31.745

5.  Host and Bacterial Markers that Differ in Children with Cystitis and Pyelonephritis.

Authors:  Nader Shaikh; Judith M Martin; Alejandro Hoberman; Megan Skae; Linette Milkovich; Andrew Nowalk; Christi McElheny; Robert W Hickey; Diana Kearney; Massoud Majd; Eglal Shalaby-Rana; George Tseng; John F Alcorn; Jay Kolls; Marcia Kurs-Lasky; Zhiguang Huo; William Horne; Greg Lockhart; Hans Pohl; Timothy R Shope
Journal:  J Pediatr       Date:  2019-03-21       Impact factor: 4.406

Review 6.  Why Serological Responses during Cystitis are Limited.

Authors:  Hae Woong Choi; Soman N Abraham
Journal:  Pathogens       Date:  2016-02-14

7.  A highly polarized TH2 bladder response to infection promotes epithelial repair at the expense of preventing new infections.

Authors:  Jianxuan Wu; Byron W Hayes; Cassandra Phoenix; Gustavo Sosa Macias; Yuxuan Miao; Hae Woong Choi; Francis M Hughes; J Todd Purves; R Lee Reinhardt; Soman N Abraham
Journal:  Nat Immunol       Date:  2020-05-18       Impact factor: 25.606

8.  Effect of deletion of gene cluster involved in synthesis of Enterobacterial common antigen on virulence and immunogenicity of live attenuated Salmonella vaccine when delivering heterologous Streptococcus pneumoniae antigen PspA.

Authors:  Qing Liu; Xuegang Shen; Xiaoping Bian; Qingke Kong
Journal:  BMC Microbiol       Date:  2020-06-08       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.